SA 4.1 Imaging, screening & surveillance for individuals with increased hereditary breast cancer risk von Delaloge, S.

Volltext

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials von Dieci, M.V., Mathieu, M.C., Guarneri, V., Conte, P., Delaloge, S., Andre, F., Goubar, A.

Volltext

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study von Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.

Volltext

OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative m... von Robson, M.E., Tung, N., Conte, P., Im, S.-A., Senkus, E., Xu, B., Masuda, N., Delaloge, S., Li, W., Armstrong, A., Wu, W., Goessl, C., Runswick, S., Domchek, S.M.

Volltext

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study von Dieci, M.V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M.C., Delaloge, S., Curigliano, G., Andre, F.

Volltext

Survival benefits of PARP inhibitors in advanced breast cancer: a mirage? von Grinda, T., Delaloge, S.

Volltext

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase... von Montemurro, F., Delaloge, S., Barrios, C.H., Wuerstlein, R., Anton, A., Brain, E., Hatschek, T., Kelly, C.M., Peña-Murillo, C., Yilmaz, M., Donica, M., Ellis, P.

Volltext

Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy? von Bailleux, C., Lacroix, L., Barranger, E., Delaloge, S.

Volltext

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE):... von Swain, S.M., Ewer, M.S., Viale, G., Delaloge, S., Ferrero, J.-M., Verrill, M., Colomer, R., Vieira, C., Werner, T.L., Douthwaite, H., Bradley, D., Waldron-Lynch, M., Kiermaier, A., Eng-Wong, J., Dang, C.

Volltext

Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis von Ferreira, A.R., Di Meglio, A., Pistilli, B., Gbenou, A.S., El-Mouhebb, M., Dauchy, S., Charles, C., Joly, F., Everhard, S., Lambertini, M., Coutant, C., Cottu, P., Lerebours, F., Petit, T., Dalenc, F., Rouanet, P., Arnaud, A., Martin, A., Berille, J., Ganz, P.A., Partridge, A.H., Delaloge, S., Michiels, S., Andre, F., Vaz-Luis, I.

Volltext

Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization? von Berrada, N., Delaloge, S., André, F.

Volltext

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2– advanced breast cancer (BELLE-4) von Martín, M., Chan, A., Dirix, L., O’Shaughnessy, J., Hegg, R., Manikhas, A., Shtivelband, M., Krivorotko, P., Batista López, N., Campone, M., Ruiz Borrego, M., Khan, Q.J., Beck, J.T., Ramos Vázquez, M., Urban, P., Goteti, S., Di Tomaso, E., Massacesi, C., Delaloge, S.

Volltext

Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer von Cottu, P., D'Hondt, V., Dureau, S., Lerebours, F., Desmoulins, I., Heudel, P.-E., Duhoux, F.P., Levy, C., Mouret-Reynier, M.-A., Dalenc, F., Frenel, J.-S., Jouannaud, C., Venat-Bouvet, L., Nguyen, S., Ferrero, J.-M., Canon, J.-L., Grenier, J., Callens, C., Gentien, D., Lemonnier, J., Vincent-Salomon, A., Delaloge, S.

Volltext

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement von Azim, H.A., Michiels, S., Zagouri, F., Delaloge, S., Filipits, M., Namer, M., Neven, P., Symmans, W.F., Thompson, A., André, F., Loi, S., Swanton, C.

Volltext

Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review von Prelaj, A, Miskovic, V, Zanitti, M, Trovo, F, Genova, C, Viscardi, G, Rebuzzi, S E, Mazzeo, L, Provenzano, L, Kosta, S, Favali, M, Spagnoletti, A, Castelo-Branco, L, Dolezal, J, Pearson, A T, Lo Russo, G, Proto, C, Ganzinelli, M, Giani, C, Ambrosini, E, Turajlic, S, Au, L, Koopman, M, Delaloge, S, Kather, J N, de Braud, F, Garassino, M C, Pentheroudakis, G, Spencer, C, Pedrocchi, A L G

Volltext

Computed-aided diagnosis (CAD) in the detection of breast cancer von Dromain, C, Boyer, B, Ferré, R, Canale, S, Delaloge, S, Balleyguier, C

Volltext

ESMO Guidance for Reporting Oncology real-World evidence (GROW) von Castelo-Branco, L., Pellat, A., Martins-Branco, D., Valachis, A., Derksen, J.W.G., Suijkerbuijk, K.P.M., Dafni, U., Dellaporta, T., Vogel, A., Prelaj, A., Groenwold, R.H.H., Martins, H., Stahel, R., Bliss, J., Kather, J., Ribelles, N., Perrone, F., Hall, P.S., Dienstmann, R., Booth, C.M., Pentheroudakis, G., Delaloge, S., Koopman, M.

Volltext

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic... von Pierga, J.-Y., Hajage, D., Bachelot, T., Delaloge, S., Brain, E., Campone, M., Diéras, V., Rolland, E., Mignot, L., Mathiot, C., Bidard, F.-C.

Volltext

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification von Trapani, D., Franzoi, M.A., Burstein, H.J., Carey, L.A., Delaloge, S., Harbeck, N., Hayes, D.F., Kalinsky, K., Pusztai, L., Regan, M.M., Sestak, I., Spanic, T., Sparano, J., Jezdic, S., Cherny, N., Curigliano, G., Andre, F.

Volltext

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer von Bidard, F.-C., Mathiot, C., Delaloge, S., Brain, E., Giachetti, S., de Cremoux, P., Marty, M., Pierga, J.-Y.

Volltext